+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Hepatitis B Virus Surface Antibody Test Kit Market - Global Forecast 2026-2032

  • Report

  • 189 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6120881
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Hepatitis B Virus Surface Antibody Test Kit Market is projected to reach USD 1.29 Billion in 2026. It is expected to continue growing at a CAGR of 7.14%, reaching USD 1.95 Billion by 2032.

Hepatitis B Surface Antibody Test Kits Support Immunity Assessment

Hepatitis B virus surface antibody test kits detect antibodies associated with immunity to hepatitis B. They are used to assess vaccination response, identify evidence of previous exposure, support clinical evaluation, and guide follow-up testing. Demand is shaped by immunization programs, blood-safety protocols, prenatal screening pathways, occupational-health requirements, and the need to distinguish susceptible individuals from those with established immunity. Interpretation generally requires the surface antibody result to be considered alongside other hepatitis B markers and the patient’s clinical history.

Screening Integration and Workflow Efficiency Are Reshaping Use

The landscape is shifting toward testing pathways that connect laboratories, hospitals, primary-care settings, occupational-health services, and public-health programs. Greater emphasis on standardized specimen handling, clear result interpretation, quality assurance, and rapid reporting is improving the practical value of antibody testing. Multiplex hepatitis B panels and reflex-testing algorithms can reduce fragmented decision-making, while decentralized and near-patient workflows may improve access where laboratory infrastructure is limited. Regulatory compliance, lot consistency, external quality assessment, and compatibility with laboratory information systems remain important adoption considerations.

Artificial Intelligence Can Improve Interpretation and Operations Without Replacing Clinical Judgment

Artificial intelligence can support demand planning, inventory management, sample-routing optimization, anomaly detection, and quality-control monitoring for hepatitis B surface antibody testing. In clinical information systems, machine-learning tools may help identify incomplete hepatitis B serology panels, flag results requiring contextual review, and connect testing with vaccination or follow-up workflows. These applications depend on representative training data, transparent validation, cybersecurity, and safeguards against automation bias. AI should assist qualified professionals rather than independently determine diagnosis or immunity status, particularly when results are ambiguous or affected by immunosuppression and timing after vaccination.

Regional Priorities Reflect Uneven Burden, Immunization Coverage, and Laboratory Access

North America is characterized by established vaccination, screening, and laboratory-quality frameworks, with continued attention to underserved populations and migrant health. Latin America combines expanding prevention programs with differences in laboratory access, financing, and rural service coverage. Europe benefits from mature public-health systems and strong quality requirements, while national approaches to screening and reimbursement vary. The Middle East is influenced by migrant populations, occupational screening, and hospital-based testing capacity. Africa faces substantial needs for accessible hepatitis services, reliable supply chains, and integration of testing with immunization and maternal-health programs. Asia-Pacific spans highly developed laboratory markets and settings where decentralized testing, vaccination follow-up, and broader access remain central priorities.

Multilateral and Regional Groups Emphasize Prevention, Standardization, and Access

ASEAN countries generally prioritize scalable immunization, maternal screening, and laboratory access across diverse health systems. BRICS members encompass large and varied populations, making supply continuity, affordability, and integration with national hepatitis programs important themes. The European Union places strong emphasis on harmonized quality, privacy, procurement, and cross-border health cooperation. G7 countries typically focus on high-quality surveillance, elimination-oriented public-health strategies, and support for innovation and resilient supply chains. GCC states commonly emphasize migrant screening, hospital quality systems, and coordinated public-health policies. NATO members may encounter operational needs involving military health, occupational screening, deployment readiness, and interoperability across participating health services.

Country-Level Needs Vary Across Vaccination, Screening, and Laboratory Systems

Australia combines comprehensive immunization and laboratory services with targeted attention to remote and priority populations. Brazil’s large and diverse health system places importance on public-program integration, regional access, and dependable procurement. Canada emphasizes evidence-based immunization, provincial health-system coordination, and access across geographically dispersed communities. China’s priorities include broad prevention, hospital laboratory capacity, and consistent testing across urban and rural settings. France, Germany, Italy, and Spain operate within mature European frameworks while applying distinct screening, reimbursement, and procurement practices. India’s scale makes affordability, decentralized access, vaccination follow-up, and public-health integration especially important. Japan and South Korea combine advanced laboratory infrastructure with strong quality expectations and aging-population considerations. Mexico continues to require coordinated prevention, screening access, and service delivery across varied regions. Russia’s needs include laboratory reliability, vaccination monitoring, and access across expansive geography. The United Kingdom emphasizes national guidance, laboratory quality, targeted screening, and continuity across devolved health systems. The United States combines extensive clinical and public-health testing with attention to health disparities, occupational exposure, prenatal care, and interpretation within broader hepatitis B serology.

Leaders Should Prioritize Assay Quality, Connected Workflows, and Equitable Access

Industry leaders should maintain rigorous analytical validation, lot-to-lot consistency, traceability, and clear instructions for use. Products should fit established serology algorithms, support efficient laboratory workflows, and provide unambiguous interpretation guidance without overstating what a surface-antibody result can establish alone. Partnerships with public-health agencies, hospitals, vaccination providers, and reference laboratories can improve implementation and feedback. Supply-chain resilience should include qualified sourcing, contingency inventory, regional service capability, and compliance with applicable regulatory requirements. Digital connectivity and carefully governed AI can strengthen reporting and quality management, provided privacy, cybersecurity, human oversight, and post-market monitoring are built into deployment. Access strategies should account for rural facilities, lower-resource laboratories, training needs, and differences in reimbursement and procurement systems.

Methodology Combines Clinical Context, Health-System Review, and Geographic Comparison

This executive summary uses a qualitative, evidence-oriented framework focused on the role of hepatitis B surface antibody test kits in immunity assessment and related testing pathways. The analysis considers established clinical use, vaccination and public-health practices, laboratory workflow requirements, regulatory and quality considerations, digital-health applications, and access conditions. Regional, group, and country observations are synthesized from the supplied coverage requirements and general health-system characteristics. No market estimates, market shares, forecasts, or company-specific claims are used. Interpretation should be paired with current clinical guidelines, local regulatory requirements, and validated product documentation.

Reliable Antibody Testing Strengthens Hepatitis B Prevention and Follow-Up

Hepatitis B surface antibody test kits remain a practical component of serologic assessment, particularly when used within complete testing algorithms and linked to vaccination, clinical, and public-health workflows. The most durable opportunities for improvement involve dependable assay performance, transparent interpretation, resilient distribution, and broader access to qualified testing. Regional and national differences require adaptable implementation rather than a single operating model. With responsible use of digital tools and AI, strong quality systems, and continued alignment with prevention programs, testing can better support immunity assessment and hepatitis B control.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Hepatitis B Virus Surface Antibody Test Kit Market, by Technology
7.1. Introduction
7.2. Chemiluminescence Immunoassay
7.2.1. Fully Automated
7.2.2. Semi-Automated
7.3. Enzyme-Linked Immunosorbent Assay
7.3.1. Microplate
7.3.2. Rapid Elisa
7.4. Lateral Flow Immunoassay
7.4.1. Cassette
7.4.2. Strip
8. Hepatitis B Virus Surface Antibody Test Kit Market, by Sample Type
8.1. Introduction
8.2. Plasma
8.3. Serum
8.4. Whole Blood
9. Hepatitis B Virus Surface Antibody Test Kit Market, by End User
9.1. Introduction
9.2. Clinics
9.3. Diagnostic Laboratories
9.4. Hospitals
9.5. Research Institutes
10. Hepatitis B Virus Surface Antibody Test Kit Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Supply
10.3. Laboratory Supply
10.4. Online Pharmacy
10.5. Retail Pharmacy
11. Hepatitis B Virus Surface Antibody Test Kit Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Hepatitis B Virus Surface Antibody Test Kit Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Hepatitis B Virus Surface Antibody Test Kit Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. Access Bio, Inc.
15.3. Alere Inc.
15.4. Autobio Diagnostics Co., Ltd.
15.5. Beckman Coulter, Inc.
15.6. Becton, Dickinson and Company
15.7. Bharat Biotech International Ltd.
15.8. bioMérieux SA
15.9. Bio-Rad Laboratories, Inc.
15.10. Danaher Corporation
15.11. DiaSorin S.p.A.
15.12. ELITechGroup Inc.
15.13. F. Hoffmann-La Roche Ltd.
15.14. Hangzhou Biotest Biotech Co., Ltd.
15.15. InBios International, Inc.
15.16. MedMira Inc.
15.17. Ortho Clinical Diagnostics, Inc.
15.18. Quidel Corporation
15.19. Siemens AG
15.20. Siemens Healthcare Diagnostics Inc.
15.21. Snibe Co., Ltd.
15.22. Sysmex Corporation
15.23. Thermo Fisher Scientific Inc.
15.24. Wantai Biological Pharmacy Enterprise Co., Ltd.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Hepatitis B Virus Surface Antibody Test Kit Market, Years Considered for the Study
FIGURE 2. Global Hepatitis B Virus Surface Antibody Test Kit Market, Research Design
FIGURE 3. Global Hepatitis B Virus Surface Antibody Test Kit Market, Research Framework
FIGURE 4. Global Hepatitis B Virus Surface Antibody Test Kit Market, Data Triangulation
FIGURE 5. Global Hepatitis B Virus Surface Antibody Test Kit Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 7. Global Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 9. Global Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Hepatitis B Virus Surface Antibody Test Kit Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Hepatitis B Virus Surface Antibody Test Kit Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Hepatitis B Virus Surface Antibody Test Kit Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Hepatitis B Virus Surface Antibody Test Kit Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Hepatitis B Virus Surface Antibody Test Kit Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Hepatitis B Virus Surface Antibody Test Kit Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Hepatitis B Virus Surface Antibody Test Kit Market Segmentation & Coverage
TABLE 2. Global Hepatitis B Virus Surface Antibody Test Kit Market Size, 2017-2032 (USD Million)
TABLE 3. Global Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 4. Global Chemiluminescence Immunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Chemiluminescence Immunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Chemiluminescence Immunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Fully Automated Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Fully Automated Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Fully Automated Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Semi-Automated Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Semi-Automated Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Semi-Automated Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Enzyme-Linked Immunosorbent Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Enzyme-Linked Immunosorbent Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Enzyme-Linked Immunosorbent Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Microplate Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Microplate Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Microplate Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Rapid Elisa Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Rapid Elisa Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Rapid Elisa Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Lateral Flow Immunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Lateral Flow Immunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Lateral Flow Immunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Cassette Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Cassette Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Cassette Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Strip Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Strip Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Strip Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 32. Global Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Serum Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Serum Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Serum Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Whole Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Whole Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Whole Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 42. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 55. Global Hospital Supply Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Hospital Supply Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Hospital Supply Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Laboratory Supply Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Laboratory Supply Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Laboratory Supply Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Hepatitis B Virus Surface Antibody Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Hepatitis B Virus Surface Antibody Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Hepatitis B Virus Surface Antibody Test Kit Market Size, by Chemiluminescence Immunoassay, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Hepatitis B Virus Surface Antibody Test Kit Market Size, by Enzyme-Linked Immunosorbent Assay, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Hepatitis B Virus Surface Antibody Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 76. North America Hepatitis B Virus Surface Antibody Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. North America Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 78. North America Hepatitis B Virus Surface Antibody Test Kit Market Size, by Chemiluminescence Immunoassay, 2017-2032 (USD Million)
TABLE 79. North America Hepatitis B Virus Surface Antibody Test Kit Market Size, by Enzyme-Linked Immunosorbent Assay, 2017-2032 (USD Million)
TABLE 80. North America Hepatitis B Virus Surface Antibody Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 81. North America Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 82. North America Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 83. North America Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 84. Latin America Hepatitis B Virus Surface Antibody Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Latin America Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 86. Latin America Hepatitis B Virus Surface Antibody Test Kit Market Size, by Chemiluminescence Immunoassay, 2017-2032 (USD Million)
TABLE 87. Latin America Hepatitis B Virus Surface Antibody Test Kit Market Size, by Enzyme-Linked Immunosorbent Assay, 2017-2032 (USD Million)
TABLE 88. Latin America Hepatitis B Virus Surface Antibody Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 89. Latin America Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 90. Latin America Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 91. Latin America Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 92. Europe Hepatitis B Virus Surface Antibody Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Europe Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 94. Europe Hepatitis B Virus Surface Antibody Test Kit Market Size, by Chemiluminescence Immunoassay, 2017-2032 (USD Million)
TABLE 95. Europe Hepatitis B Virus Surface Antibody Test Kit Market Size, by Enzyme-Linked Immunosorbent Assay, 2017-2032 (USD Million)
TABLE 96. Europe Hepatitis B Virus Surface Antibody Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 97. Europe Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 98. Europe Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 99. Europe Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 100. Middle East Hepatitis B Virus Surface Antibody Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Middle East Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 102. Middle East Hepatitis B Virus Surface Antibody Test Kit Market Size, by Chemiluminescence Immunoassay, 2017-2032 (USD Million)
TABLE 103. Middle East Hepatitis B Virus Surface Antibody Test Kit Market Size, by Enzyme-Linked Immunosorbent Assay, 2017-2032 (USD Million)
TABLE 104. Middle East Hepatitis B Virus Surface Antibody Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 105. Middle East Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 106. Middle East Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 107. Middle East Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 108. Africa Hepatitis B Virus Surface Antibody Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Africa Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 110. Africa Hepatitis B Virus Surface Antibody Test Kit Market Size, by Chemiluminescence Immunoassay, 2017-2032 (USD Million)
TABLE 111. Africa Hepatitis B Virus Surface Antibody Test Kit Market Size, by Enzyme-Linked Immunosorbent Assay, 2017-2032 (USD Million)
TABLE 112. Africa Hepatitis B Virus Surface Antibody Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 113. Africa Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 114. Africa Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 115. Africa Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 116. Global Hepatitis B Virus Surface Antibody Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. ASEAN Hepatitis B Virus Surface Antibody Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. ASEAN Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 119. ASEAN Hepatitis B Virus Surface Antibody Test Kit Market Size, by Chemiluminescence Immunoassay, 2017-2032 (USD Million)
TABLE 120. ASEAN Hepatitis B Virus Surface Antibody Test Kit Market Size, by Enzyme-Linked Immunosorbent Assay, 2017-2032 (USD Million)
TABLE 121. ASEAN Hepatitis B Virus Surface Antibody Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 122. ASEAN Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 123. ASEAN Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 124. ASEAN Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 125. GCC Hepatitis B Virus Surface Antibody Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. GCC Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 127. GCC Hepatitis B Virus Surface Antibody Test Kit Market Size, by Chemiluminescence Immunoassay, 2017-2032 (USD Million)
TABLE 128. GCC Hepatitis B Virus Surface Antibody Test Kit Market Size, by Enzyme-Linked Immunosorbent Assay, 2017-2032 (USD Million)
TABLE 129. GCC Hepatitis B Virus Surface Antibody Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 130. GCC Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 131. GCC Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 132. GCC Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 133. European Union Hepatitis B Virus Surface Antibody Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. European Union Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 135. European Union Hepatitis B Virus Surface Antibody Test Kit Market Size, by Chemiluminescence Immunoassay, 2017-2032 (USD Million)
TABLE 136. European Union Hepatitis B Virus Surface Antibody Test Kit Market Size, by Enzyme-Linked Immunosorbent Assay, 2017-2032 (USD Million)
TABLE 137. European Union Hepatitis B Virus Surface Antibody Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 138. European Union Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 139. European Union Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 140. European Union Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 141. BRICS Hepatitis B Virus Surface Antibody Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. BRICS Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 143. BRICS Hepatitis B Virus Surface Antibody Test Kit Market Size, by Chemiluminescence Immunoassay, 2017-2032 (USD Million)
TABLE 144. BRICS Hepatitis B Virus Surface Antibody Test Kit Market Size, by Enzyme-Linked Immunosorbent Assay, 2017-2032 (USD Million)
TABLE 145. BRICS Hepatitis B Virus Surface Antibody Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 146. BRICS Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 147. BRICS Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 148. BRICS Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 149. G7 Hepatitis B Virus Surface Antibody Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. G7 Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 151. G7 Hepatitis B Virus Surface Antibody Test Kit Market Size, by Chemiluminescence Immunoassay, 2017-2032 (USD Million)
TABLE 152. G7 Hepatitis B Virus Surface Antibody Test Kit Market Size, by Enzyme-Linked Immunosorbent Assay, 2017-2032 (USD Million)
TABLE 153. G7 Hepatitis B Virus Surface Antibody Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 154. G7 Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 155. G7 Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 156. G7 Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 157. NATO Hepatitis B Virus Surface Antibody Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 158. NATO Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 159. NATO Hepatitis B Virus Surface Antibody Test Kit Market Size, by Chemiluminescence Immunoassay, 2017-2032 (USD Million)
TABLE 160. NATO Hepatitis B Virus Surface Antibody Test Kit Market Size, by Enzyme-Linked Immunosorbent Assay, 2017-2032 (USD Million)
TABLE 161. NATO Hepatitis B Virus Surface Antibody Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 162. NATO Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 163. NATO Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. NATO Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 165. Global Hepatitis B Virus Surface Antibody Test Kit Market Size, by Country, 2017-2032 (USD Million)
TABLE 166. United States Hepatitis B Virus Surface Antibody Test Kit Market Size, 2017-2032 (USD Million)
TABLE 167. United States Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 168. United States Hepatitis B Virus Surface Antibody Test Kit Market Size, by Chemiluminescence Immunoassay, 2017-2032 (USD Million)
TABLE 169. United States Hepatitis B Virus Surface Antibody Test Kit Market Size, by Enzyme-Linked Immunosorbent Assay, 2017-2032 (USD Million)
TABLE 170. United States Hepatitis B Virus Surface Antibody Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 171. United States Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 172. United States Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 173. United States Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 174. Canada Hepatitis B Virus Surface Antibody Test Kit Market Size, 2017-2032 (USD Million)
TABLE 175. Canada Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 176. Canada Hepatitis B Virus Surface Antibody Test Kit Market Size, by Chemiluminescence Immunoassay, 2017-2032 (USD Million)
TABLE 177. Canada Hepatitis B Virus Surface Antibody Test Kit Market Size, by Enzyme-Linked Immunosorbent Assay, 2017-2032 (USD Million)
TABLE 178. Canada Hepatitis B Virus Surface Antibody Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 179. Canada Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 180. Canada Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. Canada Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 182. Mexico Hepatitis B Virus Surface Antibody Test Kit Market Size, 2017-2032 (USD Million)
TABLE 183. Mexico Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 184. Mexico Hepatitis B Virus Surface Antibody Test Kit Market Size, by Chemiluminescence Immunoassay, 2017-2032 (USD Million)
TABLE 185. Mexico Hepatitis B Virus Surface Antibody Test Kit Market Size, by Enzyme-Linked Immunosorbent Assay, 2017-2032 (USD Million)
TABLE 186. Mexico Hepatitis B Virus Surface Antibody Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 187. Mexico Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 188. Mexico Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. Mexico Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 190. Brazil Hepatitis B Virus Surface Antibody Test Kit Market Size, 2017-2032 (USD Million)
TABLE 191. Brazil Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 192. Brazil Hepatitis B Virus Surface Antibody Test Kit Market Size, by Chemiluminescence Immunoassay, 2017-2032 (USD Million)
TABLE 193. Brazil Hepatitis B Virus Surface Antibody Test Kit Market Size, by Enzyme-Linked Immunosorbent Assay, 2017-2032 (USD Million)
TABLE 194. Brazil Hepatitis B Virus Surface Antibody Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 195. Brazil Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 196. Brazil Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 197. Brazil Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 198. United Kingdom Hepatitis B Virus Surface Antibody Test Kit Market Size, 2017-2032 (USD Million)
TABLE 199. United Kingdom Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 200. United Kingdom Hepatitis B Virus Surface Antibody Test Kit Market Size, by Chemiluminescence Immunoassay, 2017-2032 (USD Million)
TABLE 201. United Kingdom Hepatitis B Virus Surface Antibody Test Kit Market Size, by Enzyme-Linked Immunosorbent Assay, 2017-2032 (USD Million)
TABLE 202. United Kingdom Hepatitis B Virus Surface Antibody Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 203. United Kingdom Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 204. United Kingdom Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. United Kingdom Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 206. Germany Hepatitis B Virus Surface Antibody Test Kit Market Size, 2017-2032 (USD Million)
TABLE 207. Germany Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 208. Germany Hepatitis B Virus Surface Antibody Test Kit Market Size, by Chemiluminescence Immunoassay, 2017-2032 (USD Million)
TABLE 209. Germany Hepatitis B Virus Surface Antibody Test Kit Market Size, by Enzyme-Linked Immunosorbent Assay, 2017-2032 (USD Million)
TABLE 210. Germany Hepatitis B Virus Surface Antibody Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 211. Germany Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 212. Germany Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. Germany Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 214. France Hepatitis B Virus Surface Antibody Test Kit Market Size, 2017-2032 (USD Million)
TABLE 215. France Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 216. France Hepatitis B Virus Surface Antibody Test Kit Market Size, by Chemiluminescence Immunoassay, 2017-2032 (USD Million)
TABLE 217. France Hepatitis B Virus Surface Antibody Test Kit Market Size, by Enzyme-Linked Immunosorbent Assay, 2017-2032 (USD Million)
TABLE 218. France Hepatitis B Virus Surface Antibody Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 219. France Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 220. France Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 221. France Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 222. Russia Hepatitis B Virus Surface Antibody Test Kit Market Size, 2017-2032 (USD Million)
TABLE 223. Russia Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 224. Russia Hepatitis B Virus Surface Antibody Test Kit Market Size, by Chemiluminescence Immunoassay, 2017-2032 (USD Million)
TABLE 225. Russia Hepatitis B Virus Surface Antibody Test Kit Market Size, by Enzyme-Linked Immunosorbent Assay, 2017-2032 (USD Million)
TABLE 226. Russia Hepatitis B Virus Surface Antibody Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 227. Russia Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 228. Russia Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 229. Russia Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 230. Italy Hepatitis B Virus Surface Antibody Test Kit Market Size, 2017-2032 (USD Million)
TABLE 231. Italy Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 232. Italy Hepatitis B Virus Surface Antibody Test Kit Market Size, by Chemiluminescence Immunoassay, 2017-2032 (USD Million)
TABLE 233. Italy Hepatitis B Virus Surface Antibody Test Kit Market Size, by Enzyme-Linked Immunosorbent Assay, 2017-2032 (USD Million)
TABLE 234. Italy Hepatitis B Virus Surface Antibody Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 235. Italy Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 236. Italy Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 237. Italy Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 238. Spain Hepatitis B Virus Surface Antibody Test Kit Market Size, 2017-2032 (USD Million)
TABLE 239. Spain Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 240. Spain Hepatitis B Virus Surface Antibody Test Kit Market Size, by Chemiluminescence Immunoassay, 2017-2032 (USD Million)
TABLE 241. Spain Hepatitis B Virus Surface Antibody Test Kit Market Size, by Enzyme-Linked Immunosorbent Assay, 2017-2032 (USD Million)
TABLE 242. Spain Hepatitis B Virus Surface Antibody Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 243. Spain Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 244. Spain Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. Spain Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 246. China Hepatitis B Virus Surface Antibody Test Kit Market Size, 2017-2032 (USD Million)
TABLE 247. China Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 248. China Hepatitis B Virus Surface Antibody Test Kit Market Size, by Chemiluminescence Immunoassay, 2017-2032 (USD Million)
TABLE 249. China Hepatitis B Virus Surface Antibody Test Kit Market Size, by Enzyme-Linked Immunosorbent Assay, 2017-2032 (USD Million)
TABLE 250. China Hepatitis B Virus Surface Antibody Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 251. China Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 252. China Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 253. China Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 254. India Hepatitis B Virus Surface Antibody Test Kit Market Size, 2017-2032 (USD Million)
TABLE 255. India Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 256. India Hepatitis B Virus Surface Antibody Test Kit Market Size, by Chemiluminescence Immunoassay, 2017-2032 (USD Million)
TABLE 257. India Hepatitis B Virus Surface Antibody Test Kit Market Size, by Enzyme-Linked Immunosorbent Assay, 2017-2032 (USD Million)
TABLE 258. India Hepatitis B Virus Surface Antibody Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 259. India Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 260. India Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 261. India Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 262. Japan Hepatitis B Virus Surface Antibody Test Kit Market Size, 2017-2032 (USD Million)
TABLE 263. Japan Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 264. Japan Hepatitis B Virus Surface Antibody Test Kit Market Size, by Chemiluminescence Immunoassay, 2017-2032 (USD Million)
TABLE 265. Japan Hepatitis B Virus Surface Antibody Test Kit Market Size, by Enzyme-Linked Immunosorbent Assay, 2017-2032 (USD Million)
TABLE 266. Japan Hepatitis B Virus Surface Antibody Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 267. Japan Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 268. Japan Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 269. Japan Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 270. Australia Hepatitis B Virus Surface Antibody Test Kit Market Size, 2017-2032 (USD Million)
TABLE 271. Australia Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 272. Australia Hepatitis B Virus Surface Antibody Test Kit Market Size, by Chemiluminescence Immunoassay, 2017-2032 (USD Million)
TABLE 273. Australia Hepatitis B Virus Surface Antibody Test Kit Market Size, by Enzyme-Linked Immunosorbent Assay, 2017-2032 (USD Million)
TABLE 274. Australia Hepatitis B Virus Surface Antibody Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 275. Australia Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 276. Australia Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 277. Australia Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 278. South Korea Hepatitis B Virus Surface Antibody Test Kit Market Size, 2017-2032 (USD Million)
TABLE 279. South Korea Hepatitis B Virus Surface Antibody Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 280. South Korea Hepatitis B Virus Surface Antibody Test Kit Market Size, by Chemiluminescence Immunoassay, 2017-2032 (USD Million)
TABLE 281. South Korea Hepatitis B Virus Surface Antibody Test Kit Market Size, by Enzyme-Linked Immunosorbent Assay, 2017-2032 (USD Million)
TABLE 282. South Korea Hepatitis B Virus Surface Antibody Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 283. South Korea Hepatitis B Virus Surface Antibody Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 284. South Korea Hepatitis B Virus Surface Antibody Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 285. South Korea Hepatitis B Virus Surface Antibody Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 286. Global Hepatitis B Virus Surface Antibody Test Kit Market Share, by Key Player, 2025
TABLE 287. Global Hepatitis B Virus Surface Antibody Test Kit Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Access Bio, Inc.
  • Alere Inc.
  • Autobio Diagnostics Co., Ltd.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bharat Biotech International Ltd.
  • bioMérieux SA
  • Bio‑Rad Laboratories, Inc.
  • Danaher Corporation
  • DiaSorin S.p.A.
  • ELITechGroup Inc.
  • F. Hoffmann‑La Roche Ltd.
  • Hangzhou Biotest Biotech Co., Ltd.
  • InBios International, Inc.
  • MedMira Inc.
  • Ortho Clinical Diagnostics, Inc.
  • Quidel Corporation
  • Siemens AG
  • Siemens Healthcare Diagnostics Inc.
  • Snibe Co., Ltd.
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Wantai Biological Pharmacy Enterprise Co., Ltd.